The researchers suggest clinicians might tailor their approach to account for Asian Americans' younger average age when they ...

Pain is challenging, but it doesn't have to define your life. Episode 2 of Get Tough on Multiple Sclerosis offers practical ...

Researchers from the Netherlands Institute for Neuroscience (NIN) have discovered new potential therapeutic targets for ...

The Breakthrough Prizes have been awarded annually since 2013 to recognize accomplishments in fundamental physics, ...

A new study suggests that high doses of vitamin D supplements could help reduce disease activity among multiple sclerosis ...

NEW YORK, April 08, 2025 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX), today announced the presentation of data highlighting BRIUMVI® (ublituximab-xiiy) in patients with relapsing forms of ...

Bob Wagner has spent the last six years fighting against the symptoms of multiple sclerosis. He shared his story with TMJ4 to help raise awareness of the disease.

Tolebrutinib phase 3 data published in NEJM demonstrate benefit on disability progression in multiple sclerosis Results from the HERCULES phase 3 study showed delay in disability progression in people ...

2, 2024 — Researchers have found a potential new way to improve the treatment of multiple sclerosis (MS) using a novel combined therapy. The results build on two harmonized Phase I clinical ...